US FDA Guidance on Using Bayesian Statistics in Medical Device Clinical Trials
This article was originally published in SRA
Executive Summary
Roger Sewell and Elisabeth Crowe analyse the agency’s new guidance and explain how device sponsors can benefit from using the Bayesian approach.